The principal aim of this study was to examine the therapeutic efficacy of STA in the treatment of NAFLD and to elucidate the role of the PPARγ signaling pathway in mediating the effects of STA. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.